단기지속한쪽신경통형두통발작에 대한 오나보툴리눔독소A 치료 효과의 장기 관찰
Long-term Observation of Therapeutic Effect of Onabotulinumtoxin A on Shortlasting Unilateral Neuralgiform Headache Attacks with Conjunctival Injection and Tearing
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is a rare primary headache disorder characterized by severe intractable stabbing headache and accompanying tearing and conjunctival injections. In this report, we present a case of a patient with SUNCT who achieved sustained remarkable improvement more than 6 months following successful treatment with a single session of botulinum toxin A, after being refractory or intolerant to several preventives for 4 months.
Abstract
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is a rare primary headache disorder characterized by severe intractable stabbing headache and accompanying tearing and conjunctival injections. In this report, we present a case of a patient with SUNCT who achieved sustained remarkable improvement more than 6 months following successful treatment with a single session of botulinum toxin A, after being refractory or intolerant to several preventives for 4 months.
참고문헌 (6)
- Kang MK, "SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks : debates and an update", Cephalalgia, 44, pp.3331024241232256~ (2024)
- Lambru G, "Medical treatment of SUNCT and SUNA : a prospective openlabel study including single-arm meta-analysis", J Neurol Neurosurg Psychiatry, 92, pp.233~241 (2021)
- Zabalza RJ, "Sustained response to botulinum toxin in SUNCT syndrome", Cephalalgia, 32, pp.869~872 (2012)
- Zhang Y, "Botulinum toxin A for the treatment of a child with SUNCT syndrome", Pain Res Manag, 2016, pp.8016065~ (2016)
- Choi B, "A case of short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing(SUNCT)which showed a favorable response with pregabalin", Korean J Headache, 17, pp.29~32 (2016)
- Sandrini G, "Botulinum neurotoxin type A for the treatment of pain : not just in migraine and trigeminal neuralgia", J Headache Pain, 18, pp.38~ (2017)